Back to Journals » Biologics: Targets and Therapy » Volume 17 » default

Biologics: Targets and Therapy

ISSN: 1177-5491

Archive: Volume 17, 2023

The Effect of Two Years of Secukinumab Treatment on Bone Metabolism in Patients with Radiographic Axial Spondyloarthritis: Results from Daily Clinical Practice

Siderius M, Kieskamp SC, Wink F, Kroese FGM, Arends S, Spoorenberg A

Biologics: Targets and Therapy 2023, 17:161-166

Published Date: 14 December 2023

Tocilizumab Vs Methotrexate in a Cohort of Patients Affected by Active GCA: A Comparative Clinical and Ultrasonographic Study

Grazzini S, Conticini E, Falsetti P, D'Alessandro M, Sota J, Terribili R, Baldi C, Fabiani C, Bargagli E, Cantarini L, Frediani B

Biologics: Targets and Therapy 2023, 17:151-160

Published Date: 1 December 2023

Serum LINC00152 and UCA1 in HCV-Induced Hepatocellular Carcinoma: Clinical Significance and Prognostic Value

Shehab-Eldeen S, Essa A, Arafat ES, Sleem AS, Alhosary AA, Darwish E, Essa A, Al-Omair OA, Al-Khoufi EA, Al Abdulqader AK, Nada A

Biologics: Targets and Therapy 2023, 17:137-149

Published Date: 13 October 2023

Treatment Persistence of Apremilast Among Patients with Psoriatic Arthritis

Haddad A, Stein N, Lavi I, Shynkar L, Bergman I, Feldhamer I, Cohen AD, Saliba W, Zisman D

Biologics: Targets and Therapy 2023, 17:129-136

Published Date: 4 October 2023

New Uracil Analog with Exocyclic Methylidene Group Can Reverse Resistance to Taxol in MCF-7 Cancer Cells

Długosz-Pokorska A, Perlikowska R, Janecki T, Janecka A

Biologics: Targets and Therapy 2023, 17:69-83

Published Date: 15 May 2023

Treating Alpelisib-Induced Hyperinsulinemia in Patients with Advanced Breast Cancer – A Real-Life Experience

Percik R, Oedegaard Smith C, Leibovici A, Shai A

Biologics: Targets and Therapy 2023, 17:61-67

Published Date: 3 May 2023

Hypereosinophilic Dermatitis: Successful Treatment with Dupilumab

Wu C, Zhang J, Zhao Y

Biologics: Targets and Therapy 2023, 17:57-60

Published Date: 20 April 2023

Demonstration of Safety in Wild Type Mice of npFOXF1, a Novel Nanoparticle-Based Gene Therapy for Alveolar Capillary Dysplasia with Misaligned Pulmonary Veins

Kohram F, Deng Z, Zhang Y, Reza AA, Li E, Kolesnichenko OA, Shukla S, Ustiyan V, Gomez-Arroyo J, Acharya A, Shi D, Kalinichenko VV, Kenny AP

Biologics: Targets and Therapy 2023, 17:43-55

Published Date: 20 March 2023

Elevated Serum Vinculin in Patients with HBV/HCV-Associated Liver Cirrhosis and Hepatocellular Carcinoma: A Pilot Study

Essa A, Essa ES, El-deeb SM, Seleem HEM, Al Sahlawi M, Al-Omair OA, Shehab-Eldeen S

Biologics: Targets and Therapy 2023, 17:23-32

Published Date: 19 March 2023

The Cancer Driver Genes IDH1 and IDH2 and CD204 in WHO-Grade 4 Astrocytoma: Crosstalk Between Cancer Metabolism and Tumour Associated Macrophage Recruitment in Tumour Microenvironment

Kurdi M, Mulla N, Katib Y, Alsinani T, Hakamy S, MJ Addas B, Malibary H, Halawa TF, S Farhan M, Faizo E, Baeesa S

Biologics: Targets and Therapy 2023, 17:15-22

Published Date: 5 February 2023

Preliminary Assessment of Safety and Tolerability of Avacopan During the Early Access Program for ANCA-Associated Vasculitis

van Leeuwen JR, Popov T, Obergfell A, Rabelink TJ, Teng YKO

Biologics: Targets and Therapy 2023, 17:11-14

Published Date: 25 January 2023

Significance of Interleukin 23 in Systemic Lupus Patients: Relation to Disease Activity and Damage Indices

Haroon MM, Hegazy GA, Hassanien MA, Shaker O, Hussein WH

Biologics: Targets and Therapy 2023, 17:1-9

Published Date: 18 January 2023